Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03879434
Other study ID # OSTCMC-PMCF-DE-2018-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 2, 2019
Est. completion date August 2024

Study information

Verified date April 2024
Source TRB Chemedica AG
Contact Raphaela Geiger
Phone +49 89 461483-27
Email geiger@trbchemedica.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

PMCF study to observe the routine application of Ostenil® Mini in the treatment of pain and restricted mobility in degenerative and traumatic changes of the CMC joint.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Subjects = 18 years of age and in good general health condition - Signed informed consent - Existing OstenilĀ® Mini recommendation for the treatment of rhizarthrosis Exclusion Criteria: - Known hypersensitivity to one of the OstenilĀ® Mini components - Known pregnancy or lactating females - Presence of coagulation disorder - Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts - Subjects unable to understand informed consent or having a high probability of non compliance to the study procedures and / or non completion of the study according to investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ostenil® Mini
Ostenil® Mini is a CE-certified viscoelastic solution for injection into the Joint cavity, containing 1.0 % sodium hyaluronate from fermentation

Locations

Country Name City State
Germany MVZ Berlin Freiheit 1 Berlin
Germany Orthopädie am Kiesteich Berlin
Germany Orthopädie am Tauentzien Berlin
Germany Orthopädie Wannsee Berlin
Germany Praxis für Orthopädie und Unfallchirurgie Berlin
Germany Wirbelsäulen Gelenk Zentrum Westend Berlin

Sponsors (1)

Lead Sponsor Collaborator
TRB Chemedica AG

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Pain Intensity compared to Baseline (VAS-slider) Evaluation of Pain Intensity by the Patient on a 10 cm VAS-slider. (10 cm equal the worst pain) Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Change of Subjective Therapy Evaluation (FIHOA Questionnaire, 4 grade scale) compared to Baseline Functional Index for Hand OsteoArthritis (FIHOA) to assess hand-OA related functional impairment on a 4-grade scale Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Change of Subjective Quality of Life Evaluation (Questionnaire with 5 Point Likert scale) compared to Baseline Questionnaire to assess hand-OA related Quality of Life on a 5-grade scale Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Change of Subjective Symptom Evaluation (Overall Impression on a scale from 1 to 5) The Change of Overall Subjective Symptom Evaluation on a scale from 1 (much improved) to 5 (much worse) Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Incidence of Treatment-Emergent Adverse Events Up to Day 252 after the last injection
Primary Change of Key Pinch Strength compared to Baseline (Pinch Gauge) Measurement of Key Pinch in kilograms with a Pinch Gauge Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Change of Tip Pinch Strength compared to Baseline (Pinch Gauge) Measurement of Tip Pinch in kilograms with a Pinch Gauge Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
Primary Change of Palmar Pinch Strength compared to Baseline (Pinch Gauge) Measurement of Palmar Pinch in kilograms with a Pinch Gauge Day 7, Day 14, Day 84 after last injection, Day 168 after last injection
See also
  Status Clinical Trial Phase
Recruiting NCT04829565 - Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb Phase 4
Recruiting NCT05047744 - Dual Mobility Total Joint Prosthesis (Touch) for Thumb Carpometacarpal Joint Osteoarthritis N/A
Active, not recruiting NCT04115085 - Study of Medical Ultrasound for Rhizarthrosis N/A
Recruiting NCT06078189 - Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy
Completed NCT03320291 - Long-term Evaluation of Primary Trapeziectomy and Placement of a RegJoint Implant in the Treatment of Rhizarthrosis N/A
Completed NCT04587570 - Rhizarthrosis Study N/A
Completed NCT02676284 - Durolane SJ for Treatment of Rhizarthrosis N/A
Recruiting NCT05597930 - New 3D Printed Wrist Orthosis N/A
Completed NCT03431584 - Effects on the Pain of an Infiltration by Acid Hyaluronic Association and Corticoids Versus Only Corticoids in the Rhizarthrosis. Phase 4
Active, not recruiting NCT03089723 - Saline Lavage X Saline Lavage and Osteonil® Mini in Rizarthritis N/A
Recruiting NCT01233739 - Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis. Phase 4
Completed NCT05915962 - Biological Characterization Study of an Autograft Nanofat (Nanocarabio) N/A
Not yet recruiting NCT04588961 - Trapeziectomy Suspensionplasty Versus Carpometacarpal Joint Replacement in Treatment of Basal Thumb Osteoarthritis N/A
Terminated NCT03020368 - Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint N/A
Completed NCT05169099 - Post-operative Results of the Trapezometacarpal (TMC) Prosthesis for Advanced Pre-operative Deformities
Not yet recruiting NCT05708430 - Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis Phase 2